LON:RENX

Renalytix (RENX) Share Price, News & Analysis

Renalytix logo
GBX 5.50 +0.15 (+2.80%)
As of 11/17/2026 11:10 AM Eastern

About Renalytix Stock (LON:RENX)

Advanced

Key Stats

Today's Range
5.22
▼
5.50
50-Day Range
5.10
▼
6.40
52-Week Range
1.60
▼
7.33
Volume
540,817 shs
Average Volume
1.05 million shs
Market Capitalization
£36.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S. Food and Drug Administration and which is being designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit www.kidneyintelx.com). For more information, visit www.renalytix.com.

Receive RENX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RENX Stock News Headlines

Renalytix And 2 British AI Healthcare Stocks To Watch
My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
Renalytix falls 8% as further funding may be needed
Renalytix Plc Share Chat (RENX)
See More Headlines

RENX Stock Analysis - Frequently Asked Questions

Renalytix's stock was trading at GBX 5.80 at the start of the year. Since then, RENX stock has decreased by 5.2% and is now trading at GBX 5.50.

Renalytix Plc (LON:RENX) announced its earnings results on Tuesday, October, 1st. The company reported GBX (31) earnings per share for the quarter. Renalytix had a positive trailing twelve-month return on equity of 675.00% and a negative net margin of 506.25%.

Shares of RENX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
LON:RENX
CIK
N/A
Fax
N/A
Employees
102
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (3)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£109.93 million
Net Margins
-506.25%
Pretax Margin
N/A
Return on Equity
675.00%
Return on Assets
-93.54%

Debt

Debt-to-Equity Ratio
-483.33
Current Ratio
1.57
Quick Ratio
2.42

Sales & Book Value

Annual Sales
£3 million
Price / Sales
12.29
Cash Flow
GBX 3 per share
Price / Cash Flow
1.84
Book Value
GBX (10.71) per share
Price / Book
-0.51

Miscellaneous

Outstanding Shares
670,459,000
Free Float
N/A
Market Cap
£36.88 million
Optionable
Not Optionable
Beta
1.71
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (LON:RENX) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners